The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126591492 12659149 2 F 201608 20160823 20160817 20160831 EXP US-PFIZER INC-2016384048 PFIZER 51.00 YR F Y 61.22000 KG 20160831 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126591492 12659149 1 PS EFFEXOR XR VENLAFAXINE HYDROCHLORIDE 1 Oral 75 MG, SINGLE (ONE DOSE ONLY) Y 20699 75 MG PROLONGED-RELEASE CAPSULE
126591492 12659149 2 C ATENOLOL. ATENOLOL 1 Oral 25 MG, 1X/DAY 0 25 MG TABLET QD
126591492 12659149 3 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 Oral 40 MG, 1X/DAY 0 40 MG TABLET QD
126591492 12659149 4 C ALEVE NAPROXEN SODIUM 1 Oral UNK (THREE TABLETS BY MOUTH OVER THE LAST TWO WEEKS) 0 TABLET
126591492 12659149 5 C ADVIL IBUPROFEN 1 Oral UNK, (ONE TABLET BY MOUTH, HAS TAKEN ABOUT 3 TABLETS OVER THE LAST TWO WEEKS) 0 TABLET
126591492 12659149 6 C CYCLOBENZAPRINE CYCLOBENZAPRINE 1 Oral 5 MG, AS NEEDED 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126591492 12659149 1 Hot flush
126591492 12659149 2 Hypertension
126591492 12659149 3 Barrett's oesophagus
126591492 12659149 4 Back pain
126591492 12659149 5 Headache
126591492 12659149 6 Back disorder

Outcome of event

Event ID CASEID OUTC COD
126591492 12659149 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126591492 12659149 Abnormal dreams
126591492 12659149 Asthenia
126591492 12659149 Condition aggravated
126591492 12659149 Decreased appetite
126591492 12659149 Dizziness
126591492 12659149 Dyskinesia
126591492 12659149 Eating disorder
126591492 12659149 Head discomfort
126591492 12659149 Heart rate increased
126591492 12659149 Insomnia
126591492 12659149 Limb discomfort
126591492 12659149 Loss of consciousness
126591492 12659149 Musculoskeletal disorder
126591492 12659149 Mydriasis
126591492 12659149 Nausea
126591492 12659149 Nervous system disorder
126591492 12659149 Off label use
126591492 12659149 Paraesthesia
126591492 12659149 Tremor
126591492 12659149 Vision blurred
126591492 12659149 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126591492 12659149 1 20160808 20160808 0
126591492 12659149 3 2006 0
126591492 12659149 4 2015 0
126591492 12659149 6 201606 0